Upcoming Reports [full schedule to be confirmed]

Schedule of Publications 2022

2022

Oct

  • MAIN Mental health

    Mental Health Edition

  • MAIN Neuroscience with subanalyses

    Neurological Edition

  • MAIN Autoimmune with subanalyses

    Autoimmune Edition

Sep

  • MAIN Respiratory

    Respiratory Edition

  • MAIN Rare diseases with Bleeding disorders as subanalyses

    Rare Diseases Edition

  • MAIN Italy

    Italy Edition

Aug

  • MAIN Spain

    Spain Edition

  • MAIN Asia

    Asia Edition

    Published

  • MAIN Germany

    Germany Edition

    Published

Jul

  • MAIN UK

    UK Edition

    Published

  • MAIN France

    France Edition

    Published

Jun

  • ESG report

    Published

  • MAIN Canada

    Canada Edition

    Published

  • MAIN HIV/AIDS

    HIV/AIDS Edition

    Published

May

  • MAIN Cancer [including subanalyses]

    Cancer Edition

    Published

  • MAIN USA

    USA Edition

    Published

Apr

  • MAIN Global

    Global Edition

    Published

2021

Oct

  • Corporate Reputation of Pharma 2021 – mental health edition

    Mental Health Edition

    Published

  • Corporate Reputation of Pharma 2021 – neurological edition

    Neurological Edition

    Published

  • Corporate Reputation of Pharma 2021 – autoimmune edition

    Autoimmune Edition

    Published

Sep

  • Corporate Reputation of Pharma 2021 – Respiratory Edition

    Respiratory Edition

    Published

  • Corporate Reputation of Pharma 2021 – Bleeding Disorders Edition

    Bleeding disorders edition, Rare Diseases Edition

    Published

  • Corporate Reputation of Pharma 2021 – Spain Edition

    Spain Edition

    Published

  • Corporate Reputation of Pharma 2021 – Italy Edition

    Italy Edition

    Published

Aug

  • Realigning Patient Centricity Strategies after a pandemic

    Toolkits for Pharma

    Published

  • Corporate Reputation of Pharma 2021 – Asia Edition

    Asia Edition

    Published

Jul

  • Corporate Reputation of Pharma 2021 – Germany Edition

    Germany Edition

    Published

  • Corporate Reputation of Pharma 2021 – UK Edition

    UK Edition

    Published

  • Corporate Reputation of Pharma 2021 – France Edition

    France Edition

    Published

Jun

  • Corporate Reputation of Pharma 2021 – Canada Edition

    Canada Edition

    Published

  • Corporate Reputation of Pharma 2021 – HIV/AIDS Edition

    HIV/AIDS Edition

    Published

May

  • Corporate Reputation of Pharma 2021 – Cancer Edition

    Cancer Edition

    Published

  • Corporate Reputation of Pharma 2021 – USA Edition

    USA Edition

    Published

Apr

  • Corporate Reputation of Pharma 2021 – Global Edition

    Global Edition

    Published

2020

Sep

  • Patient relations

    The Experience of PATIENT ORGANISATIONS During the Covid-19 Global Pandemic

    Published

Up